NEW BRUNSWICK, N.J.,
April 20, 2015 /PRNewswire/
-- Johnson & Johnson (NYSE: JNJ) will host a review of its
Pharmaceutical business for the investment community beginning at
8:30 a.m. (Eastern Time) on
Wednesday, May 20, 2015 at the Hyatt
Regency Hotel in New Brunswick, New
Jersey and ending at approximately 3:00 p.m.
Paul Stoffels, M.D., Worldwide
Chairman Pharmaceuticals, and Chief Scientific Officer and
Joaquin Duato, Worldwide Chairman,
Pharmaceuticals will host the meeting. Dominic Caruso, Vice President, Finance and
Chief Financial Officer will provide opening remarks. The
meeting will feature presentations from the therapeutic area
leaders within the Pharmaceutical Research and Development
organization.
The agenda for the day will be posted on the Investor Relations
website on approximately May
13th.
Investors and other interested parties may access this meeting
by visiting the Company's website at www.investor.jnj.com for a
simultaneous webcast of the presentations.
A replay and podcast will be available shortly after the live
webcast through www.investor.jnj.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-host-pharmaceutical-business-review-300068667.html
SOURCE Johnson & Johnson